• Back To Industries Listing
• Practice Areas
• Industries

• Biotechnology
• Financial Services
• Life Sciences
• Medical Devices
• Pharmaceutical
• Therapeutics

• Patent
• Technology & IP Litigation

Diagnostics

Increasingly sophisticated diagnostic methods and devices are being employed throughout the life sciences sector to rapidly treat diseases, eliminate ineffective drug regimines and generally improve patient care and outcomes. The diagnostics industry is competitive and constantly evolving. Sullivan & Worcester works with successful diagnostic companies to secure funding for their missions, defend their intellectual property, advise on business collaborations and provide guidance with government laws and regulations.

Representative Client Work

• Acted as general outside counsel to a publicly-traded life sciences company that develops nanoparticle technology for use in pharmaceutical compounds and as diagnostic agents
• Represented a life sciences company in connection with a freedom to operate analysis related to peptide nucleic acid technologies and nucleic acid amplification technologies
• Represented numerous biotechnology and life sciences firms in negotiating federal grant funding (including SBIRs, CRADAs, and other funding vehicles), with particular emphasis on protecting our clients' intellectual property, and compliance with government regulations
• Represented a life sciences company on a series of joint venture agreements in the area of neonatal and prenatal testing
• Represented a leading provider of liquid control solutions used to confirm the performance of medical diagnostic testing devices in its $31M sale to a British public limited company
• Representing a life sciences company engaged in the development and marketing of high performance, low-cost, micro-engineered systems for biopolymer analysis in its initial round of equity financing
• Represented a medical device company with the strategic development and prosecution of its patent portfolio related to breast biopsy and cryoablation devices
• Represented a medical diagnostics company with the strategic development and prosecution of its patent portfolio related to non-invasive blood testing and symptom based nucleic acid diagnostics